Join to View Full Profile
4921 Parkview Pl# DvSaint Louis, MO 63110
Phone+1 314-362-7216
Fax+1 314-362-8813
Dr. Ajufo is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Helen Ajufo, MD, based in Saint Louis, MO, is an internal medicine specialist with subspecialties in hematology and oncology. She completed her fellowship in Hematology and Medical Oncology at Memorial Sloan Kettering Cancer Center (2021-2024) and her residency at the University of Texas Health Science Center at Houston (2017-2021). She holds an MS in Clinical Science from UTMB (2015-2016) and graduated in 2016 from the University of Texas Medical Branch School of Medicine. Her research includes publications on hematology topics such as venous thromboembolism in polycythemia vera, myelofibrosis, and myeloproliferative neoplasms, featured in journals like Hematology, European Journal of Haematology, and British Journal of Haematology.
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2021 - 2024
University of Texas Health Science Center at HoustonResidency, 2017 - 2021
UTMBMS, Clinical Science, 2015 - 2016
University of Texas Medical Branch School of MedicineClass of 2016
Certifications & Licensure
IL State Medical License 2024 - 2026
MO State Medical License 2024 - 2026
NY State Medical License 2023 - 2025
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Efficacy and safety of nivolumab plus ipilimumab in patients with metastatic variant histology (non-clear cell) renal cell carcinoma.Mohammad Jad Moussa, Jaanki Khandelwal, Nathaniel R Wilson, Kiran L Malikayil, Devaki Shilpa Surasi
Journal for Immunotherapy of Cancer. 2025-02-12 - Pacritinib Response Is Associated With Overall Survival in Myelofibrosis: PERSIST-2 Landmark Analysis of Survival.Helen Ajufo, Jan Philipp Bewersdorf, Claire Harrison, Francesca Palandri, John Mascarenhas
European Journal of Haematology. 2025-02-01 - Impact of Recent Translational and Therapeutic Developments on Clinical Course of BCR::ABL1-Positive and -Negative Myeloproliferative Neoplasms.Tariq I Mughal, John Mascarenhas, Raajit K Rampal, Prithviraj Bose, Thomas Lion
Hematological Oncology. 2025-01-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
